Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing
2024 · Acta Pharmaceutica Sinica B · 11 citations
https://doi.org/10.1016/j.apsb.2024.06.028
W
Wenkang Fu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
376
Citations
12
h-index
14
i10-index
Wenkang Fu is an academic researcher. The author has contributed to research in topics: Cholangiocarcinoma and Gallbladder Cancer Studies & MicroRNA in disease regulation & Pancreatic and Hepatic Oncology Research. The author has an h-index of 12, co-authored 34 publications.
Papers by this author
worksSaline irrigation for reducing the recurrence of common bile duct stones after lithotripsy: a randomized controlled trial
2023 · EClinicalMedicine · 7 citations
https://doi.org/10.1016/j.eclinm.2023.101978
Biological and genetic characterization of a newly established human primary multidrug-resistant distal cholangiocarcinoma cell line, CBC3T-6
2024 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-024-81392-0
Additional file 2 of Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.23908855
Additional file 1 of Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.12177759
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat